The prognostic importance of miR-21 in stage II colon cancer: a population-based study

被引:85
作者
Kjaer-Frifeldt, S. [1 ,2 ]
Hansen, T. F. [1 ]
Nielsen, B. S. [3 ]
Joergensen, S. [3 ]
Lindebjerg, J. [4 ]
Soerensen, F. B. [2 ,4 ]
Christensen, R. dePont [2 ]
Jakobsen, A. [1 ,2 ]
机构
[1] Vejle Hosp, Danish Colorectal Canc Grp S, Dept Oncol, Vejle, Denmark
[2] Univ So Denmark, Odense, Denmark
[3] Exiqon AS, Diagnost Product Dev, DK-2950 Vedbaek, Denmark
[4] Vejle Hosp, Dept Clin Pathol, Vejle, Denmark
关键词
colon cancer; miRNA-21; population study; prognostic marker; stage II; ADJUVANT CHEMOTHERAPY; MICRORNA EXPRESSION; COLORECTAL-CANCER; STROMA; RECOMMENDATIONS; OVEREXPRESSION; IDENTIFICATION; METASTASIS; INVASION; MARKERS;
D O I
10.1038/bjc.2012.365
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
BACKGROUND: Despite several years of research and attempts to develop prognostic models a considerable fraction of stage II colon cancer patients will experience relapse within few years from their operation. The aim of the present study was to investigate the prognostic importance of miRNA-21 (miR-21), quantified by in situ hybridisation, in a unique, large population-based cohort. PATIENTS AND METHODS: The study included 764 patients diagnosed with stage II colon cancer in Denmark in the year 2003. One section from a representative paraffin-embedded tumour tissue specimen from each patient was processed for analysis of miR-21 and quantitatively assessed by image analysis. RESULTS: The miR-21 signal was predominantly observed in fibroblast-like cells located in the stromal compartment of the tumours. We found that patients expressing high levels of miR-21 had significantly inferior recurrence-free cancer-specific survival (RF-CSS): HR = 1.26; 95% CI: 1.15-1.60; P < 0.001. In Cox regression analysis, a high level of miR-21 retained its prognostic importance and was found to be significantly related to poor RF-CSS: HR 1.41; 95% CI: 1.19-1.67; P < 0.001. CONCLUSION: The present study showed that increasing miR-21 expression levels were significantly correlated to decreasing RF-CSS. Further investigations of the clinical importance of miR-21 in the selection of high-risk stage II colon cancer patients are merited. British Journal of Cancer (2012) 107, 1169-1174. doi:10.1038/bjc.2012.365 www.bjcancer.com (c) 2012 Cancer Research UK
引用
收藏
页码:1169 / 1174
页数:6
相关论文
共 30 条
[1]
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer [J].
Asangani, I. A. ;
Rasheed, S. A. K. ;
Nikolova, D. A. ;
Leupold, J. H. ;
Colburn, N. H. ;
Post, S. ;
Allgayer, H. .
ONCOGENE, 2008, 27 (15) :2128-2136
[2]
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues [J].
Bandres, E. ;
Cubedo, E. ;
Agirre, X. ;
Malumbres, R. ;
Zarate, R. ;
Ramirez, N. ;
Abajo, A. ;
Navarro, A. ;
Moreno, I. ;
Monzo, M. ;
Garcia-Foncillas, J. .
MOLECULAR CANCER, 2006, 5 (1)
[3]
Bastos Diogo Assed, 2010, Ther Adv Med Oncol, V2, P261, DOI 10.1177/1758834010367905
[4]
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer [J].
Benson, AB ;
Schrag, D ;
Somerfield, MR ;
Cohen, AM ;
Figueredo, AT ;
Flynn, PJ ;
Krzyzanowska, MK ;
Maroun, J ;
McAllister, P ;
Van Cutsem, E ;
Brouwers, M ;
Charette, M ;
Haller, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3408-3419
[5]
Role of microRNAs in plant and animal development [J].
Carrington, JC ;
Ambros, V .
SCIENCE, 2003, 301 (5631) :336-338
[6]
Chan SH, 2008, ANTICANCER RES, V28, P907
[7]
Non-coding RNAs: Identification of Cancer-Associated microRNAs by Gene Profiling [J].
Ferdin, Jana ;
Kunej, Tanja ;
Calin, George A. .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2010, 9 (02) :123-138
[8]
Adjuvant therapy for completely resected stage II colon cancer [J].
Figueredo, Alvaro ;
Coombes, Megan E. ;
Mukherjee, Som .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03)
[9]
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators [J].
Gabriely, Galina ;
Wurdinger, Thomas ;
Kesari, Santosh ;
Esau, Christine C. ;
Burchard, Julja ;
Linsley, Peter S. ;
Krichevsky, Anna M. .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (17) :5369-5380
[10]
Molecular markers to individualize adjuvant therapy for colon cancer [J].
Gangadhar, Tara ;
Schilsky, Richard L. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) :318-325